While cases of progression on mTOR inhibitors have been documented, this case highlights how aggressive malignant PEComas invading the mediastinum can behave and the need for more population-based studies to guide treatment paradigms in inoperable patients. The gene discussed is MTOR; the disease is neoplasm with perivascular epithelioid cell differentiation.